T. Damci Et Al. , "Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients," DIABETES CARE , vol.27, no.5, pp.1077-1080, 2004
Damci, T. Et Al. 2004. Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients. DIABETES CARE , vol.27, no.5 , 1077-1080.
Damci, T., YALIN, S., Balci, H., Osar, Z., KORUGAN, Ü., ÖZYAZAR, M., ... Ilkova, H. M.(2004). Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients. DIABETES CARE , vol.27, no.5, 1077-1080.
Damci, Taner Et Al. "Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients," DIABETES CARE , vol.27, no.5, 1077-1080, 2004
Damci, Taner Et Al. "Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients." DIABETES CARE , vol.27, no.5, pp.1077-1080, 2004
Damci, T. Et Al. (2004) . "Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients." DIABETES CARE , vol.27, no.5, pp.1077-1080.
@article{article, author={Taner DAMCI Et Al. }, title={Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients}, journal={DIABETES CARE}, year=2004, pages={1077-1080} }